Watson Pharmaceuticals Inc. intends to appeal the U.S. District Court for the Southern District of Florida’s decision that the Company’s naproxen sodium product infringes Elan Corporation Plc’s patent No. 5,637,320.
On…
Discovery is ongoing in Duramed Pharmaceuticals, Inc.’s lawsuit alleging that sales of the Company’s Quasense TM tablets infringes Duramed’s U.S. Patent No. RE 39,861.
On Dec. 13, 2007, Duramed sued the…
The trial of the matter entitled Elan Corporation PLC v. Andrx Pharmaceuticals, Inc., Case No. 058- 0158, has been scheduled for April 27, 2009, according to Watson Pharmaceuticals Inc.’s Form…
Watson Pharmaceuticals Inc.’s subsidiary, Watson Laboratories, Inc., pursues a patent infringement lawsuit against Barr Laboratories, Inc. and its parent company, Barr Pharmaceuticals, Inc., in the U.S. District Court for the…